| Variable |
CMC (n = 101) |
OMC (n = 28) |
PMC (n = 54) |
P |
| Age (years) |
43.5 ± 9 7 |
38.7 ± 10 4 |
431 ± 9.8 |
0.071 |
| Sex F/M |
73/28 |
16/12 |
44/10 |
0.063 |
| BMI kg/m2 |
24.2 ± 3.9 |
23.3 ± 3 |
23.9 ± 3 |
0.48 |
| NYHA class III - IV |
59 (58.4%) |
18 (64.3%) |
34 (63%) |
0.78 |
| CTI |
0.57 ± 0.06 |
0.58 ± 0.08 |
0.56 ± 0.05 |
0.31 |
| AF n (%) |
73 (72.3%) |
16 (57%) |
33 (61%) |
0.19 |
| Preop CVA n (%) |
2 (2%) |
3 (10.7%) |
3 (5.6%) |
0.11 |
| Renal dysfunction |
3 (3%) |
0 (0%) |
2 (3.7%) |
0.6 |
| CPOD (%) |
6 (5.9%) |
1 (3.6%) |
1 (1.9%) |
0.48 |
| LA diameter mm |
53.9 ± 8,3 |
58 ± 12.5 |
52 ± 9.2 |
0.032 |
| LV ESD mm |
33.9 ± 6 |
34.5 ± 7.5 |
34.4 ± 7.5 |
0.89 |
| LV EDD mm |
50.5 ± 7.2 |
53.2 ± 7.6 |
50.7 ± 8.8 |
0.3 |
| RF (%) |
32 ± 6.9 |
32.7 ± 6.8 |
31.9 ± 7.8 |
0.89 |
| LV EF (%) |
60.8 ± 9.4 |
61.5 ± 9.1 |
60 ± 9 |
0.77 |
| SPAP mmhg |
50.8 ± 20.5 |
53.4 ± 20.8 |
51.6 ± 15.7 |
0.83 |
| MVA (cm2) |
1.05 ± 0.3 |
1.26 ± 0.4 |
1.05 ± 0.2 |
<0.01 |
| Mitral valve gradient (mmhg) |
10.8 ± 4.3 |
9.3 ± 2.6 |
12.2 ± 4 |
0.2 |
| Time years Follow-up period |
16.8 ± 7.8 |
11.4 ± 4 |
7 ± 4 |
<0.01 |
| LV EF <40% |
3 (3%) |
1 (3.6%) |
2 (3.7%) |
0.96 |
| Euroscore |
4.84 ± 2 |
4.96 ± 2 |
1.73 ± 2.2 |
<0.01 |